Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT04896710COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample
NCT05798156Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP
NCT02303119Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)
NCT00459771Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
NCT01195298Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
NCT01329952Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment
NCT04059081A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment
NCT00724022Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
NCT01674738TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
NCT00205556Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients
NCT04148066ctDNA Guided Treatment of Early Resistance to Targeted Treatment
NCT01847677Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
NCT05118724Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin
NCT01898117Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer
NCT01048879Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)
NCT05971108Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
NCT01714908Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
NCT00536640Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab
NCT03820063Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study
NCT05765084Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
NCT01713218Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer
NCT02716779Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection
NCT04920981Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
NCT04653831Treatment With Pirfenidone for COVID-19 Related Severe ARDS
NCT01457144Study of Mantle Cell Lymphoma Treatment by RiBVD
NCT01306409Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
NCT00719264Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
NCT00223301Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
NCT00952003Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
NCT04487756Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
NCT02499003GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma
NCT02389283Reduced Ultrasound Counts in Rheumatoid Arthritis
NCT04332822A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
NCT00744640Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
NCT00001723Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
NCT02992704Peg-interferon for Inactive Chronic Hepatitis B Carriers
NCT02383290The Implementation of Pharmacogenomics Into Primary Care in British Columbia
NCT04161248Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
NCT01752335Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis
NCT00476502Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r
NCT01471470Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
NCT00694408A Pilot Trial of Pediatric Liver Transplantation Without Steroids
NCT05966233R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT00262717Can Resistance Enhance Selection of Treatment? (CREST)
NCT00264290Valganciclovir to Reduce T Cell Activation in HIV Infection
NCT03134794Medical Education for Better Multiple Sclerosis Outcomes
NCT00384566A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure
NCT05038657Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
NCT00645606Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia